Literature DB >> 1117754

Stimulation tests for diagnosis of medullary thyroid carcinoma.

G W Sizemore, V L Go.   

Abstract

We compared the maximal calcitonin secretion produced by pentagastrin, calcium, and glucagon for preoperative detection of medullary thyroid carcinoma in four subjects with normal or slightly increased plasma immunoreactive calcitonin (iCT) levels. In each case, pentagastrin administration produced higher peak iCT levels (5- to 36-fold increases over basal) than did calcium infusion (by 1.9- to 10.3-fold) and glucagon administration (by 3.6- to 27.4-fold). These preliminary studies suggest that pentagastrin is an effective agent for use in rapid stimulation tests designed to detectmedullary thyroid carcinoma in asymptomatic patients who have normal basal iCT concentrations.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1117754

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  14 in total

Review 1.  Diagnostic problems in pheochromocytoma.

Authors:  M Mannelli
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

2.  Multiple endocrine adenomatosis (Type I) and familial hyperparathyroidism.

Authors:  R T Jung; A M Grant; M Davie; D Jenkins; T M Chalmers
Journal:  Postgrad Med J       Date:  1978-02       Impact factor: 2.401

3.  Chromosomal instability in medullary carcinoma of the thyroid.

Authors:  N A Samaan; T C Hsu; S Pathak; M F Saad; N G Ordonez; R C Hickey
Journal:  World J Surg       Date:  1984-08       Impact factor: 3.352

Review 4.  Calcitonin: perspectives in current concepts.

Authors:  H J Wolfe
Journal:  J Endocrinol Invest       Date:  1982 Nov-Dec       Impact factor: 4.256

5.  Stimulated calcitonin cut-offs by different tests.

Authors:  Laura Fugazzola
Journal:  Eur Thyroid J       Date:  2013-01-16

6.  The surgical management of medullary thyroid carcinoma.

Authors:  C F Russell; J A Van Heerden; G W Sizemore; A J Edis; W F Taylor; W H ReMine; J A Carney
Journal:  Ann Surg       Date:  1983-01       Impact factor: 12.969

7.  Production of gastrin releasing peptide by medullary carcinoma of the thyroid. An immunohistochemical study.

Authors:  T Kameya; T Bessho; M Tsumuraya; K Yamaguchi; K Abe; Y Shimosato; N Yanaihara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

8.  Hypercalcitoninaemia in patients with pheochromocytoma.

Authors:  F Raue; J M Bayer; K H Rahn; C Herfarth; H Minne; R Ziegler
Journal:  Klin Wochenschr       Date:  1978-07-15

9.  Comparison of the effects of pentagastrin and meal-stimulated gastrin on plasma calcitonin in normal man.

Authors:  C Owyang; H Heath; G W Sizemore; V L Go
Journal:  Am J Dig Dis       Date:  1978-12

Review 10.  Drug therapy alternatives in the treatment of thyroid cancer.

Authors:  M J O'Doherty; A J Coakley
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.